Ignite Creation Date:
2025-12-24 @ 11:34 PM
Ignite Modification Date:
2026-02-01 @ 2:16 AM
Study NCT ID:
NCT02696356
Status:
COMPLETED
Last Update Posted:
2018-06-14
First Post:
2016-02-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma
Sponsor:
BrightPath Biotherapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GRN1201-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None